propidium has been researched along with troglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugelski, P; Elcock, F; Hahn, L; Hart, T; McFarland, D; Morgan, DG; Narayanan, PK; Schwartz, L; Zhang, C | 1 |
| Cui, T; Liu, L; Liu, Y; Mou, J; Pei, DS; Zhang, SN; Zhu, ZA | 1 |
2 other study(ies) available for propidium and troglitazone
| Article | Year |
|---|---|
Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Membrane; Chromans; Coloring Agents; Dose-Response Relationship, Drug; Fibrinolytic Agents; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Membrane Potentials; Mitochondria; Models, Chemical; Oxidative Stress; Oxygen; Phenanthridines; Propidium; Rats; Rosiglitazone; Superoxides; Thiazolidinediones; Troglitazone | 2003 |
Combinational effect of PPARĪ³ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Chromans; Down-Regulation; Humans; Hypoglycemic Agents; Intercalating Agents; PPAR gamma; Propidium; Proto-Oncogene Proteins c-bcl-2; Retinoid X Receptors; Stomach Neoplasms; Thiazolidinediones; Tretinoin; Troglitazone; Up-Regulation | 2013 |